Page 4 - Prosight Management News Today

Finepoint Capital LP grew its position in shares of Galapagos NV (NASDAQ:GLPG – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,359 shares of the biotechnology company’s stock after acquiring an additional 10,657 shares during the […]

Finepoint Capital LP grew its position in shares of Galapagos NV (NASDAQ:GLPG – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,359 shares of the biotechnology company’s stock after acquiring an additional 10,657 shares during the […]

Investment analysts at StockNews.com assumed coverage on shares of Galapagos (NASDAQ:GLPG – Get Rating) in a report released on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. GLPG has been the topic of a number of other reports. Morgan Stanley cut their target price on Galapagos from $44.00 to $42.00 in […]

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target raised by Cantor Fitzgerald from $11.00 to $16.00 in a research report report published on Thursday, The Fly reports. Other research analysts have also issued reports about the company. Citigroup dropped their price target on Longboard Pharmaceuticals from $24.00 to $17.00 and set a buy […]

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target increased by Cantor Fitzgerald from $11.00 to $16.00 in a report published on Thursday, The Fly reports. A number of other research firms have also weighed in on LBPH. HC Wainwright reiterated a buy rating and issued a $25.00 price objective on shares of Longboard […]

Boston Partners lifted its stake in R1 RCM Inc. (NASDAQ:RCM – Get Rating) by 204.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 2,402,194 shares of the healthcare provider’s stock after acquiring an additional 1,611,891 shares during the period. Boston Partners’ holdings in R1 RCM were worth $27,508,000 as of its most […]

Galapagos NV (NASDAQ:GLPG – Get Rating) shares gapped down before the market opened on Wednesday . The stock had previously closed at $41.00, but opened at $39.63. Galapagos shares last traded at $39.39, with a volume of 133,932 shares trading hands. Wall Street Analyst Weigh In A number of brokerages have recently weighed in on […]

EFG Asset Management North America Corp. bought a new position in R1 RCM Inc. (NASDAQ:RCM – Get Rating) in the fourth quarter, Holdings Channel reports. The firm bought 169,301 shares of the healthcare provider’s stock, valued at approximately $1,850,000. Other institutional investors also recently bought and sold shares of the company. Texas Permanent School Fund […]

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Rating) had its target price trimmed by Raymond James from $83.00 to $81.00 in a research report sent to investors on Thursday morning, The Fly reports. Several other analysts also recently commented on the stock. HC Wainwright reissued a buy rating and set a $61.00 price objective on shares of […]

Wall Street brokerages expect that NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) will report earnings of ($0.20) per share for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for NeoGenomics’ earnings, with the highest EPS estimate coming in at ($0.18) and the lowest estimate coming in at ($0.21). NeoGenomics reported earnings of […]